GeminIQ Website Logo

Viewing BTCY free

Subscribe for full history, 50+ metrics, screener, watchlist...

BIOTRICITY INC.

BTCY

Companies in Surgical & Medical Instruments & Apparatus

BIOTRICITY INC. (BTCY) — SEC Financial Statements & Analysis

BIOTRICITY INC. (BTCY) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Cash And Cash Equivalents At Carrying Value
000001001010
Assets Current
Assets Current
656555444454
Accounts Receivable Net Current
322221121222
Inventory Net
122222222222
Deposits Assets Current
111112110001
Deposits Assets Noncurrent
000000000000
Accounts Receivable Net Noncurrent
000000000000
Property Plant And Equipment Net
000000000000
Operating Lease Right Of Use Asset
001111111111
Assets
666666556576
Accounts Payable And Accrued Liabilities Current
9988889810877
Liabilities Current
Liabilities Current
372424222121212123191815
Convertible Notes Payable Current
11111010109889876
Loans Payable To Bank Current
152222233221-
Derivative Liabilities Current
000000011132
Operating Lease Liability Current
011111000000
Other Loans Payable Long Term
111111111111
Long Term Loans From Bank
-12121212129910111112
Derivative Liabilities Noncurrent
111112211111
Operating Lease Liability Noncurrent
--0001111111
Liabilities
393838373636343336323230
Temporary Equity
Temporary Equity Carrying Amount Attributable To P…
22--222-----
Preferred Stock Value
00000-------
Common Stock Value
000000000000
Additional Paid In Capital
10810810710710710510510496969393
Stockholders Equity
Stockholders Equity
-35-34-33-33-32-32-31-30-31-28-27-23
Accumulated Other Comprehensive Income Loss Net Of…
-0-0-0000-000-0-0-0
Retained Earnings Accumulated Deficit
-143-142-141-140-139-137-139-139-127-123-120-116
Liabilities And Stockholders Equity
666666556576
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
00000-------
Preferred Stock Shares Outstanding
00000-------
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
125125125125125125125125125125125125
Common Stock Shares Issued
868380807873696456565151
Shares Outstanding
29282727262423219999
Common Stock Other Shares Outstanding
666666666666

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202627.78%-4.62%5.54%-14.31%-47.53%-49.23%-4.17%-1.87%9.50%---
2025-5.12%-39.00%-17.07%-29.29%-12.50%-2.77%-24.11%-36.49%-22.73%7.60%68.28%25.62%
2024-14.05%-14.05%-59.38%20.01%30.01%-0.71%9.09%-1.99%4.41%-11.11%-56.69%-58.04%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.16
0.21
0.23
0.24
0.22
0.23
0.19
0.20
0.20
0.21
0.29
0.29
Quick Ratio
0.12
0.13
0.14
0.15
0.15
0.16
0.10
0.11
0.11
0.10
0.17
0.14
Working Capital
-31.28M
-18.82M
-18.08M
-16.66M
-16.00M
-16.28M
-17.42M
-16.49M
-18.23M
-14.69M
-12.65M
-10.70M
Leverage & Debt
Debt to Equity
-1.14
-1.12
-1.14
-1.12
-1.11
-1.12
-1.10
-1.11
-1.14
-1.16
-1.21
-1.26
Interest Coverage TTM
0.50
0.04
-0.14
-0.31
-0.75
-1.46
-1.84
-2.44
-2.92
-3.26
-4.79
-6.46
Debt Ratio
6.11
6.72
6.01
6.10
6.32
5.98
6.46
6.09
6.04
5.87
4.73
4.81
Efficiency & Turnover
Asset Turnover TTM
2.65
2.65
2.60
2.52
2.38
2.31
2.08
2.12
1.94
1.92
1.49
1.16
Days Sales Outstanding TTM
52.38
33.24
43.55
42.63
41.39
38.65
44.98
45.17
40.74
55.70
59.43
57.48
Receivables Turnover TTM
6.97
10.98
8.38
8.56
8.82
9.44
8.12
8.08
8.96
6.55
6.14
6.35
Per Share Metrics
Diluted EPS TTM
-0.09
-0.31
-0.30
-0.34
-0.55
-0.52
-0.53
-1.00
-1.57
-1.75
-1.87
-1.97
Free Cash Flow Per Share TTM
-0.03
-0.04
-0.02
-0.05
-0.11
-0.13
-0.19
-0.45
-0.74
-0.82
-1.06
-1.30
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.11
0.11
Margin Metrics
Gross Profit Margin TTM
80.94%
81.09%
79.84%
78.26%
76.61%
74.31%
73.40%
71.89%
69.27%
65.52%
61.66%
57.84%
Operating Profit Margin TTM
10.57%
0.91%
-3.11%
-7.26%
-17.76%
-34.96%
-45.57%
-62.30%
-73.18%
-79.45%
-106.12%
-128.61%
Net Profit Margin TTM
-15.03%
-56.04%
-52.76%
-61.67%
-86.60%
-94.97%
-94.76%
-115.87%
-116.84%
-135.17%
-147.78%
-162.54%
Growth Metrics
Net Revenue Growth (1Y)
16.01%
16.46%
19.51%
18.12%
14.32%
14.09%
13.55%
15.47%
25.15%
28.55%
30.50%
33.51%
Net Income Growth (1Y)
-79.87%
-31.28%
-33.46%
-37.13%
-15.27%
-19.84%
-27.19%
-17.69%
-24.46%
-58.72%
-52.85%
-58.11%
EPS Growth (1Y)
-84.13%
-39.64%
-44.09%
-66.11%
-64.61%
-70.30%
-71.53%
-49.15%
-27.25%
-60.05%
-53.67%
-58.96%
Valuation Metrics
P/E TTM
-2.68
-0.96
-1.78
-1.09
-0.61
-0.56
-0.44
-0.90
-0.94
-0.66
-1.15
-1.94
P/B
-0.19
-0.24
-0.42
-0.30
-0.23
-0.22
-0.17
-0.43
-0.42
-0.37
-0.70
-1.43
P/S TTM
0.40
0.54
0.94
0.67
0.53
0.53
0.42
1.04
1.10
0.89
1.69
3.16
Market Cap
6.44M
8.28M
14.19M
9.73M
7.32M
7.02M
5.29M
12.75M
13.31M
10.33M
18.82M
33.48M
Enterprise Value
17.41M
19.17M
24.27M
19.43M
16.57M
15.92M
13.59M
21.15M
21.76M
18.16M
24.34M
39.03M
Calculated Values
Free Cash Flow TTM
-718.96K
-1.10M
-446.64K
-1.26M
-2.38M
-3.15M
-4.36M
-6.36M
-6.69M
-7.41M
-9.28M
-11.34M
Net Debt
10.96M
10.89M
10.09M
9.69M
9.25M
8.90M
8.31M
8.40M
8.45M
7.84M
5.52M
5.55M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2021-10-11Sale
Owner: Rosa, David A
Title: -
Shares: 3,318
Price/Share: $3.05
Value: $10,119.90
Shares Owned: 125,000
Relationship: Director
Ownership: Direct
2021-09-16Sale
Owner: Rosa, David A
Title: -
Shares: 34,977
Price/Share: $3.43
Value: $119,971.11
Shares Owned: 155,027
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
0.24%
Inst. Shares: 66,596
Shares Outstanding: 27,590,766
2025-12-31
0.07%
Inst. Shares: 18,333
Shares Outstanding: 27,590,766
2025-09-30
0.18%
Inst. Shares: 48,263
Shares Outstanding: 26,767,370
2024-09-30
0.25%
Inst. Shares: 56,276
Shares Outstanding: 22,493,626
2024-06-30
2.56%
Inst. Shares: 362,103
Shares Outstanding: 14,169,441

Research Faster.
Invest Smarter.

BIOTRICITY INC. (BTCY) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.